University of Texas Southwestern Medical Center at Dallas
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-10-01 | NCT06016842 | |
| The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study | Pediatric Solid Tumor | Active, not recruiting | Not stated | 2026-09-21 | NCT02520713 | |
| Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT05239624 | |
| Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) | Depressive Disorder, Treatment-Resistant, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-08-28 | NCT06423430 | |
| Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma | Choroid Plexus Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, cerebral ventricle cancer, mixed neoplasm, neoplasm, nervous system disorder, rhabdoid tumor | Active, not recruiting | Phase 2 | 2026-05-19 | NCT00602667 | |
| Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery | Neoplasms by Site, Skin and Connective Tissue Diseases, neoplasm, skin disorder, skin neoplasm | Enrolling by invitation | Not stated | 2026-05-06 | NCT03503240 | |
| Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-04-24 | NCT03155997 | |
| Esprit BTK Post-Approval Study | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2026-03-25 | NCT06656364 | |
| LIFE-BTK Randomized Controlled Trial | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2025-12-30 | NCT04227899 | |
| Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT) | Frailty, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, depressive disorder, heart disorder, neoplasm, nervous system disorder, psychiatric disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2025-11-04 | NCT07224347 |